Tag: genetic disorder

April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March 18, 2018

5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top

Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...
March 15, 2018

Solid Biosciences Clinical Trial Put on Hold by FDA, Sends Share Price Tumbling

Negative findings include a decrease in platelet count, a reduction in red blood cell count and evidence of complement activation.
March 4, 2018

5 Top NASDAQ Biotech Stocks: Tenax on top with a 51.94 Percent Increase

This past week the NASDAQ Biotechnology Index increased by 4.15 percent reaching 3,501.80 points in the last week—nearly equal to...
February 27, 2018

The EMA Grants Accelerated Assessment for Shire’s Lanadelumab

Shire (NASDAQ: SHPG), the global biotechnology leader in rare diseases, announced today the Committee for Medicinal Products for Human Use...
February 23, 2018

FDA Accepts Shire’s BLA and Grants Priority Review for Lanadelumab

Shire (NASDAQ: SHPG) announced the U.S. Food and Drug Administration accepted the Biologics License Application and granted priority review for...